<DOC>
	<DOCNO>NCT01077843</DOCNO>
	<brief_summary>This descriptive study cohort patient ankylose spondylitis use etoricoxib population . It also include nested case-control analysis ( great equal 700 event give type available analysis ) estimate odds current exposure etoricoxib , various anti-inflammatory treatment , compare non-exposure treatment , clinical outcome interest European patient Ankylosing Spondylitis . The study population follow-up time refresh / add annually , analysis re-run annually cumulative basis 2017 .</brief_summary>
	<brief_title>Post-authorization Safety Study Etoricoxib Other Anti-inflammatory Therapies European Patients With Ankylosing Spondylitis ( MK-0663-163 )</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>A recorded Ankylosing Spondylitis diagnosis database A record AS diagnosis follow applicable `` acceptable data quality '' date database contain patient 's record At least 6 month register medical record database applicable `` acceptable data quality '' date describe , prior record AS diagnosis Complete information gender birth year</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Ankylosing Spondylitis</keyword>
</DOC>